Institute for International Research

7 New Deliverables for 2007:

• 30+ New Immunogenicity Case Studies
  
• Scientists Reveal FDA Feedback from 6 Preclinical and Clinical Immunogenicity Studies
  
• 8 Case Examples of ELISA and ECL Platform comparisons
  
• 6 Industry Leaders Layout Strategies to Determine the Affect of the Immunogenicity Profile on Pre-clinical and Clinical Programs
  
• Talk Directly to the Authors of the Immunoassay Validation White Paper and Hear How to Integrate the Most Recent Industry Practices into your Lab
  
• Troubleshoot your Most Pressing Immunogenicity Challenges with our Expanded Speaking Faculty
  
• 2 Evening Receptions to Enhance your Networking Experience